Volume 53, Issue 3 pp. 146-149

Monitoring the European standard series in 10 centres 1996–2000

D. P. Bruynzeel

Corresponding Author

D. P. Bruynzeel

Departments of (Occupational) Dermatology, VU University Medical Centre, Amsterdam, the Netherlands,

D. P. Bruynzeel
Department of Occupational Dermatology
VU University Medical Centre
De Boelelaan 1117
NL-1081 HV Amsterdam
The Netherlands
Tel: + 31 20 4440149
Fax: + 31 20 4440148
e-mail: [email protected]Search for more papers by this author
T. L. Diepgen

T. L. Diepgen

University Hospital, Heidelberg, Germany,

Search for more papers by this author
K. E. Andersen

K. E. Andersen

Odense University Hospital, University of Southern Denmark, Odense, Denmark,

Search for more papers by this author
F. M. Brandão

F. M. Brandão

Hospital Garcia de Orta, Almada, Portugal,

Search for more papers by this author
M. Bruze

M. Bruze

University Hospital Malmo, Malmo, Sweden,

Search for more papers by this author
P. J. Frosch

P. J. Frosch

University of Witten/Herdecke, Dortmund, Germany,

Search for more papers by this author
A. Goossens

A. Goossens

University Hospital KU Leuven, Belgium,

Search for more papers by this author
A. Lahti

A. Lahti

University of Oulu, Finland,

Search for more papers by this author
V. Mahler

V. Mahler

University Hospital, Erlangen, Germany,

Not a member of the EECDRG

Search for more papers by this author
H. I Maibach

H. I Maibach

UCSF School of Medicine, San Francisco, CA, USA,

Search for more papers by this author
T. Menné

T. Menné

Gentofte Hospital, Copenhagen, Denmark,

Search for more papers by this author
J. D. Wilkinson

J. D. Wilkinson

Amersham Hospital, Bucks, UK

Search for more papers by this author
First published: 26 August 2005
Citations: 69

Abstract

A 5-year retrospective study of the frequency of sensitization to the 25 allergens of the European standard series (ESS) was conducted in 10 centres in 8 European countries. Included were the results of 26 210 patients. The range in sensitivities differed moderately between the centres. Combining results of different centres and drawing conclusions on incidences can be done only with great care. The information on the ranking of the allergens and their sensitization incidence in the clinics are useful for decisions on the future composition of the standard series. The ESS is still a valid screening tool, and no substances should be deleted.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.